The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria
Open accessAbstract
-antihistamine treatment. Omalizumab binds to free IgE, which lowers free IgE levels and causes FcεRI receptors on basophils and mast cells to be downregulated. It has been shown to improve symptoms of CIU/CSU, but its mechanism of action is not currently understood. Potential mechanisms in CIU/CSU include reducing mast cell releasability, reversing basopenia and improving basophil IgE receptor function, reducing activity of IgG autoantibodies against FcεRI and IgE, reducing activity of IgE autoantibodies against an antigen or autoantigen that has yet to be definitively identified, reducing the activity of intrinsically 'abnormal' IgE, and decreasing in vitro coagulation abnormalities associated with disease activity. However, none of these theories alone or in combination fully account for the pattern of symptom improvement seen with omalizumab therapy, and therefore, no one mechanism is likely to be the definitive mechanism of action. Additional research is needed to further clarify the involvement of omalizumab in relieving symptoms associated with the complex, multifactorial pathogenesis of CIU/CSU.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zuberbier, T., Aberer, W., Asero, R., Bindslev‐Jensen, C., Brzoza, Z., Canonica, G. W., Church, M. K., Ensina, L. F., Giménez‐Arnau, A., Godse, K., et al. (2014) · Allergy · doi:10.1111/all.12313 · Cited by 1,203
Self-citationOmalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Maurer, M., Rosén, K., Hsieh, H.-J., Saini, S., Grattan, C., Gimenéz-Arnau, A., Agarwal, S., Doyle, R., Canvin, J., Kaplan, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215372 · Cited by 1,105
Self-citationHide, M., Francis, D. M., Grattan, C., Hakimi, J., Kochan, J. P., & Greaves, M. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282204 · Cited by 895
Maurer, M., Weller, K., Bindslev-Jensen, C., Giménez-Arnau, A., Bousquet, P. J., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E. H., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02496.x · Cited by 843
Self-citationMacGlashan, D. W., Bochner, B. S., Adelman, D. C., Jardieu, P. M., Togias, A., McKenzie-White, J., Sterbinsky, S. A., Hamilton, R. G., & Lichtenstein, L. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1438 · Cited by 823
The diagnosis and management of acute and chronic urticaria: 2014 update
Bernstein, J. A., Lang, D. M., Khan, D. A., Craig, T., Dreyfus, D., Hsieh, F., Sheikh, J., Weldon, D., Zuraw, B., Bernstein, D. I., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.036 · Cited by 682
Kaplan, A., Ledford, D., Ashby, M., Canvin, J., Zazzali, J. L., Conner, E., Veith, J., Kamath, N., Staubach, P., Jakob, T., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.013 · Cited by 573
Self-citationThe late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.
Solley, G. O., Gleich, G. J., Jordon, R. E., & Schroeter, A. L. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108485 · Cited by 542
Humanization of an antibody directed against IgE.
Presta, L. G., Lahr, S. J., Shields, R. L., Porter, J. P., Gorman, C. M., Fendly, B. M., & Jardieu, P. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2623 · Cited by 474
Saini, S. S., Bindslev-Jensen, C., Maurer, M., Grob, J.-J., Bülbül Baskan, E., Bradley, M. S., Canvin, J., Rahmaoui, A., Georgiou, P., Alpan, O., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.306 · Cited by 471
Self-citationMolecular regulation of mast cell activation
Rivera, J., & Gilfillan, A. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.015 · Cited by 459
Omalizumab-induced reductions in mast cell FcεRI expression and function
Beck, L. A., Marcotte, G. V., MacGlashan, D., Togias, A., & Saini, S. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.032 · Cited by 456
Self-citationZuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G. W., Church, M. K., Ensina, L. F., Giménez-Arnau, A., Godse, K., et al. (2015) · Dermatology Review · doi:10.5114/dr.2015.51433 · Cited by 428
Self-citationFujisawa, D., Kashiwakura, J.-I., Kita, H., Kikukawa, Y., Fujitani, Y., Sasaki-Sakamoto, T., Kuroda, K., Nunomura, S., Hayama, K., Terui, T., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.004 · Cited by 404
Saini, S., Rosen, K. E., Hsieh, H.-J., Wong, D. A., Conner, E., Kaplan, A., Spector, S., & Maurer, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.010 · Cited by 398
Self-citationImmunoglobulin E-independent activation of mast cell is mediated by Mrg receptors
Tatemoto, K., Nozaki, Y., Tsuda, R., Konno, S., Tomura, K., Furuno, M., Ogasawara, H., Edamura, K., Takagi, H., Iwamura, H., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.177 · Cited by 382
Chronic urticaria and autoimmunity: Associations found in a large population study
Confino-Cohen, R., Chodick, G., Shalev, V., Leshno, M., Kimhi, O., & Goldberg, A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.043 · Cited by 369
Maurer, M., Altrichter, S., Bieber, T., Biedermann, T., Bräutigam, M., Seyfried, S., Brehler, R., Grabbe, J., Hunzelmann, N., Jakob, T., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.038 · Cited by 360
Omalizumab treatment downregulates dendritic cell FcεRI expression
Prussin, C., Griffith, D. T., Boesel, K. M., Lin, H., Foster, B., & Casale, T. B. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.003 · Cited by 349
Pathogenesis of chronic urticaria
Kaplan, A. P., & Greaves, M. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03256.x · Cited by 335
Self-citationChronic urticaria: Pathogenesis and treatment
Kaplan, A. P. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.049 · Cited by 327
Self-citationNiimi, N., Francis, D. M., Kermani, F., O'Donnell, B. F., Hide, M., Kobza-Black, A., Winkelmann, R. K., Greaves, M. W., & Barr, R. M. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12338544 · Cited by 312
Prevalence and Functional Role of Anti-IgE Autoantibodies in Urticarial Syndromes
Gruber, B. L., Baeza, M. L., Marchese, M. J., Agnello, V., & Kaplan, A. P. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12462239 · Cited by 310
Self-citationFiebiger, E., Maurer, D., Holub, H., Reininger, B., Hartmann, G., Woisetschläger, M., Kinet, J. P., & Stingl, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118325 · Cited by 294
Treatment of chronic autoimmune urticaria with omalizumab
Kaplan, A. P., Joseph, K., Maykut, R. J., Geba, G. P., & Zeldin, R. K. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.006 · Cited by 286
Self-citationYing, S., Kikuchi, Y., Meng, Q., Kay, A. B., & Kaplan, A. P. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.123236 · Cited by 275
Self-citationMetz, M., Ohanyan, T., Church, M. K., & Maurer, M. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.08.011 · Cited by 274
Basophil recruitment and activation in inflammatory skin diseases: Basophils in skin diseases
Ito, Y., Satoh, T., Takayama, K., Miyagishi, C., Walls, A. F., & Yokozeki, H. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02570.x · Cited by 272
Assessment of autoimmunity in patients with chronic urticaria
Tong, L. J., Balakrishnan, G., Kochan, J. P., Kinét, J.-P., & Kaplan, A. P. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70071-x · Cited by 248
Self-citationArm, J. P., Bottoli, I., Skerjanec, A., Floch, D., Groenewegen, A., Maahs, S., Owen, C. E., Jones, I., & Lowe, P. J. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12400 · Cited by 248
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria
Chang, T. W., Chen, C., Lin, C.-J., Metz, M., Church, M. K., & Maurer, M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.04.036 · Cited by 242
Asero, R., Tedeschi, A., Riboldi, P., & Cugno, M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1343 · Cited by 226
Saini, S. S., MacGlashan, D. W., Sterbinsky, S. A., Togias, A. G., Adelman, D. C., Lichtenstein, L. M., & Bochner, B. S. (1999) · PubMed · Cited by 207
Self-citationTiming and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria
Kaplan, A., Ferrer, M., Bernstein, J. A., Antonova, E., Trzaskoma, B., Raimundo, K., Rosén, K., Omachi, T. A., Khalil, S., & Zazzali, J. L. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.023 · Cited by 203
Self-citationKonstantinou, G. N., Asero, R., Ferrer, M., Knol, E. F., Maurer, M., Raap, U., Schmid‐Grendelmeier, P., Skol, P. S., & Grattan, C. E. H. (2013) · Allergy · doi:10.1111/all.12056 · Cited by 203
Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE
Boyce, J. A. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.003 · Cited by 202
Füreder, W., Agis, H., Willheim, M., Bankl, H. C., Maier, U., Kishi, K., Müller, M. R., Czerwenka, K., Radaszkiewicz, T., Butterfield, J. H., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3152 · Cited by 193
Histologic studies of chronic idiopathic urticaria
Natbony, S. F., Phillips, M. E., Elias, J. M., Godfrey, H. P., & Kaplan, A. P. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90096-9 · Cited by 192
Self-citationSavage, J. H., Courneya, J.-P., Sterba, P. M., MacGlashan, D. W., Saini, S. S., & Wood, R. A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.05.039 · Cited by 190
Self-citationGrattan, C. E. H., Dawn, G., Gibbs, S., & Francis, D. M. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01589.x · Cited by 186
Inhibition of Allergic Reactions with Antibodies to IgE
Shields, R. L., Whether, W. R., Zioncheck, K., O’Connell, L., Fendly, B., Presta, L. G., Thomas, D., Saban, R., & Jardieu, P. (1995) · International Archives of Allergy and Immunology · doi:10.1159/000237010 · Cited by 183
Saini, S. S., MacGlashan, D. W., Sterbinsky, S. A., Togias, A., Adelman, D. C., Lichtenstein, L. M., & Bochner, B. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5624 · Cited by 181
Self-citationOmalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis
Carter, M. C., Robyn, J. A., Bressler, P. B., Walker, J. C., Shapiro, G. G., & Metcalfe, D. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.032 · Cited by 172
Takahagi, S., Mihara, S., Iwamoto, K., Morioke, S., Okabe, T., Kameyoshi, Y., & Hide, M. (2010) · Allergy · doi:10.1111/j.1398-9995.2009.02222.x · Cited by 171
Effect of omalizumab on patients with chronic urticaria
Spector, S. L., & Tan, R. A. (2007) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60644-8 · Cited by 168
Ferrer, M., Kinét, J.-P., & Kaplan, A. P. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70176-9 · Cited by 164
Self-citationSabroe, R. A., Poon, E., Orchard, G. E., Lane, D., Francis, D. M., Barr, R. M., Black, M. M., Black, A. K., & Greaves, M. W. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70475-6 · Cited by 163
Pharmaceutical approval update.
Goldenberg, M. M. (2008) · Europe PMC (PubMed Central) · Cited by 157
Eckman, J. A., Hamilton, R. G., Gober, L. M., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.55 · Cited by 156
Activation of the Coagulation Cascade in C1-Inhibitor Deficiencies
Cugno, M., Cicardi, M., Bottasso, B., Coppola, R., Paonessa, R., Mannucci, P. M., & Agostoni, A. (1997) · Blood · doi:10.1182/blood.v89.9.3213 · Cited by 156
Eggel, A., Baravalle, G., Hobi, G., Kim, B., Buschor, P., Forrer, P., Shin, J., Vogel, M., Stadler, B. M., Dahinden, C. A., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.005 · Cited by 151
Minimal Requirements for IgE-Mediated Regulation of Surface FcεRI
Borkowski, T. A., Jouvin, M., Lin, S., & Kinet, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1290 · Cited by 150
Defective histamine release in chronic urticaria.
Kern, F., & Lichtenstein, L. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108405 · Cited by 146
Prostaglandin E2–EP3 Signaling Induces Inflammatory Swelling by Mast Cell Activation
Morimoto, K., Shirata, N., Taketomi, Y., Tsuchiya, S., Segi-Nishida, E., Inazumi, T., Kabashima, K., Tanaka, S., Murakami, M., Narumiya, S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300290 · Cited by 132
Houser, D. D., Arbesman, C. E., Ito, K., & Wicher, K. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80110-3 · Cited by 129
Saini, S. S. (2013) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2013.09.012 · Cited by 127
Self-citationKay, A. B., Ying, S., Ardelean, E., Młynek, A., Kita, H., Clark, P., & Maurer, M. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12991 · Cited by 126
Anti-IgE as a mast cell–stabilizing therapeutic agent
Chang, T. W., & Shiung, Y.-Y. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.005 · Cited by 122
Predictive value of autoantibodies for activity of systemic lupus erythematosus
Reveille, J. D. (2004) · Lupus · doi:10.1191/0961203303lu1015oa · Cited by 120
New concepts in chronic urticaria
Vonakis, B. M., & Saini, S. S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.09.005 · Cited by 117
Self-citationEffects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge
Eckman, J. A., Sterba, P. M., Kelly, D., Alexander, V., Liu, M. C., Bochner, B. S., MacGlashan, D. W., & Saini, S. S. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.012 · Cited by 117
Self-citationVonakis, B. M., Vasagar, K., Gibbons, S. P., Gober, L. M., Sterba, P. M., Chang, H., & Saini, S. S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.035 · Cited by 116
Self-citationCharlesworth, E. N., Kagey-Sobotka, A., Schleimer, R. P., Norman, P. S., & Lichtenstein, L. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.2.671 · Cited by 115
Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapy
Kaplan, A. P. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.012 · Cited by 111
Self-citationKaplan, A. P., & Beaven, M. A. (1976) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12514352 · Cited by 107
Self-citationKaplan, A. P., Garofalo, J., Sigler, R. W., & Hauber, T. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110293051808 · Cited by 102
Self-citationThrombin-induced degranulation of cultured bone marrow-derived mast cells.
Razin, E., & Marx, G. S. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.6.3282 · Cited by 101
Puccetti, A., Bason, C., Simeoni, S., Millo, E., Tinazzi, E., Beri, R., Peterlana, D., Zanoni, G., Senna, G., Corrocher, R., et al. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02380.x · Cited by 99
Ong, Y. E., Menzies-Gow, A. N., Barkans, J. R., Benyahia, F., Ou, T.-T., Sun, Y., & Kay, A. B. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.035 · Cited by 97
Bossi, F., Frossi, B., Radillo, O., Cugno, M., Tedeschi, A., Riboldi, P., Asero, R., Tedesco, F., & Pucillo, C. E. M. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02704.x · Cited by 96
Grattan, C. E. H., WALPOLE, D., Francis, D. M., Niimi, N., Dootson, G., EDLER, S., Corbett, M., & Barr, R. M. (1997) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1997.1630972.x · Cited by 94
Chronic urticaria and coagulation: pathophysiological and clinical aspects
Tedeschi, A., Kolkhir, P., Asero, R., Pogorelov, D., Olisova, O. Y., Kochergin, N. G., & Cugno, M. (2014) · Allergy · doi:10.1111/all.12389 · Cited by 90
MacGlashan, D. W., Xia, H.-Z., Schwartz, L. B., & Gong, J. (2001) · PubMed · Cited by 88
Passive transfer of cold urticaria
Sherman, W. B., & Seebohm, P. M. (1950) · Journal of Allergy · doi:10.1016/0021-8707(50)90017-7 · Cited by 81
Broder, M. S., Raimundo, K., Antonova, E. N., & Chang, E. Y. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0134-8 · Cited by 78
IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcɛRI in human basophils
MacGlashan, D. W., Xia, H.-Z., Schwartz, L. B., & Gong, J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.2.207 · Cited by 76
Luquin, E., Kaplan, A. P., & Ferrer, M. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02212.x · Cited by 75
Self-citationOmalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation
MacGlashan, D. W., & Saini, S. S. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.056 · Cited by 73
Self-citationGomez, G., Jogie‐Brahim, S., Shima, M., & Schwartz, L. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1353 · Cited by 71
Prostaglandin D2 and histamine release in cold urticaria
Heavey, D. J., Kobza-Black, A., Barrow, S. E., Chappell, C. G., Greaves, M. W., & Dollery, C. T. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90033-3 · Cited by 70
Antinuclear antibodies in the oldest-old women and men
Nilsson, B.-O., Skogh, T., Ernerudh, J., Johansson, B. E. A., Löfgren, S., Wikby, A., & Dahle, C. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.10.002 · Cited by 68
Omalizumab is effective in nonautoimmune urticaria
Ferrer, M., Gamboa, P. M., Sanz, M. L., Goikoetxea, M. J., Cabrera‐Freitag, P., Javaloyes, G., Berroa, F., & Kaplan, A. P. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1085 · Cited by 65
Self-citationOmalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases
Molderings, G. J., Raithel, M., Kratz, F., Azémar, M., Haenisch, B., Harzer, S., & Homann, J. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4640 · Cited by 63
Chan, Y., Ramadani, F., Santos, A. F., Pillai, P., Ohm‐Laursen, L., Harper, C. E., Fang, C., Dodev, T. S., Wu, S., Sun, Y., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.029 · Cited by 63
MacGlashan, D. W., Savage, J. H., Wood, R. A., & Saini, S. S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.05.038 · Cited by 60
Self-citationBasophil responsiveness in chronic urticaria
Saini, S. S. (2009) · Current Allergy and Asthma Reports · doi:10.1007/s11882-009-0040-3 · Cited by 54
Self-citationLoss of receptors and IgE in vivo during treatment with anti-IgE antibody
MacGlashan, D. W. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.064 · Cited by 52
Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders
Cho, C. B., Stutes, S. A., Altrich, M. L., Ardoin, S. P., Phillips, G. S., & Ogbogu, P. U. (2012) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2012.10.020 · Cited by 51
Differential TLR ‐induced cytokine production by human mast cells is amplified by Fcɛ RI triggering
Suurmond, J., Dorjée, A. L., Knol, E. F., Huizinga, T. W. J., & Toes, R. E. M. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12509 · Cited by 46
Pharmaceutical Approval Update.
Gohil, K. (2014) · Europe PMC (PubMed Central) · Cited by 45
Ormerod, A. D., BLACK, A. K., Dawes, J., Murdoch, R. D., Koro, O., Barr, R. M., & Greaves, M. W. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90968-2 · Cited by 44
Dugina, T. N., Kiseleva, E. V., Glusa, E., & Strukova, S. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01752-7 · Cited by 34
Fukuzumi, T., Waki, N., Kanakura, Y., Nagoshi, J., Hirota, S., YOSHIKAWA, K., & Kitamura, Y. (1990) · PubMed · Cited by 30
Eckman, J. A., Hamilton, R. G., & Saini, S. S. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.416 · Cited by 29
Self-citationSugiyama, A., Nishie, H., Takeuchi, S., Yoshinari, M., & Furue, M. (2014) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2014.02.007 · Cited by 25
Ye, Y., Kim, B. E., Shin, Y. S., Park, H., & Leung, D. Y. M. (2014) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2014.03.016 · Cited by 19
Isolated late cutaneous skin test response to ampicillin: A distinct entity
Dolovich, J., Ruhno, J. W., Sauder, D. N., Ahlstedt, S., & Hargreave, F. E. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90982-7 · Cited by 18
Biologic agents and the therapy of chronic spontaneous urticaria
Kaplan, A. P., & Popov, T. A. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000083 · Cited by 13
Self-citationSaarinen, J., Harvima, R. J., Horsmanheimo, M., & Harvima, I. T. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000249 · Cited by 12
Paterniti, M. O., Breslin, L., Courneya, J.-P., Sterba, P. M., Hamilton, R. G., MacGlashan, D. W., & Saini, S. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.541 · Cited by 4
Self-citation
Cited by
Kolkhir, P., Giménez-Arnau, A. M., Kulthanan, K., Peter, J., Metz, M., & Maurer, M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00389-z · Cited by 382
Self-citationOmalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS
Lemal, R., Fouquet, G., Terriou, L., Vaes, M., Livideanu, C. B., Frenzel, L., Barete, S., Canioni, D., Lhermitte, L., Rossignol, J., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.03.039 · Cited by 70
The evolving atopic dermatitis management landscape
Sahni, V. N., Balogh, E. A., Strowd, L. C., & Feldman, S. R. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1999412 · Cited by 20
Metadata
- Authors
- Kaplan, A. P., Giménez-Arnau, A. M., & Saini, S. S.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2017-01-04
- Volume
- 72
- Issue
- 4
- Pages
- 519-533
- ISSN
- 0105-4538 (ISSN-L)
- OpenAlex
- W2556598798
- Cited by
- 293
- References
- 100
- FWCI
- 21.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.